Loading...

UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Sarah Mars, PhD

Title(s)Associate Researcher, Family Community Medicine
SchoolSchool of Medicine
Phone415-420-5667
ORCID ORCID Icon0000-0002-7109-8602 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bobashev G, Mars S, Murphy N, Dreisbach C, Zule W, Ciccarone D. Heroin type, injecting behavior, and HIV transmission. A simulation model of HIV incidence and prevalence. PLoS One. 2019; 14(12):e0215042. PMID: 31887142.
      View in: PubMed
    2. Mars SG, Rosenblum D, Ciccarone D. Fentanyl: the many challenges ahead. Addiction. 2019 05; 114(5):785-786. PMID: 30873700.
      View in: PubMed
    3. Mars SG, Rosenblum D, Ciccarone D. Illicit fentanyls in the opioid street market: desired or imposed? Addiction. 2019 05; 114(5):774-780. PMID: 30512204.
      View in: PubMed
    4. Mars SG, Ondocsin J, Ciccarone D. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduct J. 2018 05 16; 15(1):26. PMID: 29769132.
      View in: PubMed
    5. Mars SG, Ondocsin J, Ciccarone D. Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD. J Psychoactive Drugs. 2018 Apr-Jun; 50(2):167-176. PMID: 29211971.
      View in: PubMed
    6. Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'. Int J Drug Policy. 2017 08; 46:146-155. PMID: 28735775.
      View in: PubMed
    7. Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. The Textures of Heroin: User Perspectives on "Black Tar" and Powder Heroin in Two U.S. Cities. J Psychoactive Drugs. 2016 Sep-Oct; 48(4):270-8. PMID: 27440088.
      View in: PubMed
    8. Ciccarone D, Unick GJ, Cohen JK, Mars SG, Rosenblum D. Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions. Drug Alcohol Depend. 2016 Jun 01; 163:126-33. PMID: 27155756.
      View in: PubMed
    9. Mars SG, Fessel JN, Bourgois P, Montero F, Karandinos G, Ciccarone D. Heroin-related overdose: The unexplored influences of markets, marketing and source-types in the United States. Soc Sci Med. 2015 Sep; 140:44-53. PMID: 26202771.
      View in: PubMed
    10. Unick G, Rosenblum D, Mars S, Ciccarone D. The relationship between US heroin market dynamics and heroin-related overdose, 1992-2008. Addiction. 2014 Nov; 109(11):1889-98. PMID: 24938727.
      View in: PubMed
    11. Rosenblum D, Castrillo FM, Bourgois P, Mars S, Karandinos G, Unick GJ, Ciccarone D. Urban segregation and the US heroin market: a quantitative model of anthropological hypotheses from an inner-city drug market. Int J Drug Policy. 2014 May; 25(3):543-55. PMID: 24445118.
      View in: PubMed
    12. Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting. Int J Drug Policy. 2014 Mar; 25(2):257-66. PMID: 24238956.
      View in: PubMed
    13. Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PLoS One. 2013; 8(2):e54496. PMID: 23405084.
      View in: PubMed
    14. Sarah G. Mars. Unifying Hierarchs and Fragmenting Individualists. 2012 Aug 20.
      View in: Publisher Site
    15. Sarah G. Mars. 1965–2010. 2012 Aug 20.
      View in: Publisher Site
    16. Sarah G. Mars. ‘Friendly’ Visits and ‘Evil Men’. 2012 Aug 20.
      View in: Publisher Site
    17. Sarah G. Mars. Prescribing and Proscribing. 2012 Aug 20.
      View in: Publisher Site
    18. Sarah G. Mars. Introduction. 2012 Aug 20.
      View in: Publisher Site
    19. Sarah G. Mars. Ambiguous Justice. 2012 Aug 20.
      View in: Publisher Site
    20. Sarah G. Mars. Defining ‘Good Clinical Practice’. 2012 Aug 20.
      View in: Publisher Site
    21. Sarah G. Mars. Guidelines and the Licensing Question. 2012 Aug 20.
      View in: Publisher Site
    22. Sarah G. Mars. Ambiguous Justice: The General Medical Council and Dr Ann Dally. 2012 Jan 1; 65-88.
      View in: Publisher Site
    23. Sarah G Mars.. The Politics of Addiction: Medical Conflict and Drug Dependence in England since the 1960s. Science, Technology and Medicine in Modern History series. Modern HistoThe Politics of Addiction: Medical Conflict and Drug Dependence in England since the 1960s,. 2012.
    24. Mars SG, Ling PM. Meanings & motives. Experts debating tobacco addiction. Am J Public Health. 2008 Oct; 98(10):1793-802. PMID: 18703459.
      View in: PubMed
    25. Sarah Mars. Book Review. Medical History. 2005 Apr 1; 49(2):231-232.
      View in: Publisher Site
    26. SARAH MARS. The Troublesome Legacy of Commissioner Lin. The Opium Trade and Opium Suppression in Fujian Province, 1820s to 1920s. Addiction. 2005 Mar 1; 100(3):414-415.
      View in: Publisher Site
    27. Mars S. Peer pressure and imposed consensus: the making of the 1984 Guidelines of Good Clinical Practice in the Treatment of Drug Misuse. Clio Med. 2005; 75:149-83. PMID: 16212730.
      View in: PubMed
    28. Berridge V, Mars S. History of addictions. J Epidemiol Community Health. 2004 Sep; 58(9):747-50. PMID: 15310799.
      View in: PubMed
    29. Sarah Mars. Book of the Month: Heroin Addiction Care and Control: The British System 1916 to 1984. Journal of the Royal Society of Medicine. 2003 Feb 1; 96(2):99-100.
      View in: Publisher Site